Plasma derivative · BLA
Cutaquig (Immunoglobulin g) NDC 0069-1476
Human immunoglobulin g 165 mg/mL · Solution · Subcutaneous · Pfizer Laboratories Div Pfizer Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0069-1476-02 | 0006914760200069147602 | 1 VIAL, GLASS in 1 CARTON (0069-1476-02) / 12 mL in 1 VIAL, GLASS (0069-1476-01)Marketed from Sep 13, 2019 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cutaquig
- Generic name (nonproprietary)
- immunoglobulin g
- Active ingredients
- Human immunoglobulin g — 165 mg/mL
- Dosage form
- Solution
- Route
- Subcutaneous
- Labeler
- Pfizer Laboratories Div Pfizer IncNDC labeler code 0069
- Product type
- Plasma derivative
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125668
- Marketing start
- Listing expires
- Other FDA classes
- Antigen Neutralization (Mechanism)Immunoglobulins (Chemical structure)Passively Acquired Immunity (Physiologic effect)
- Identifiers
- Product ID 0069-1476_65f206aa-2273-42cd-affc-abbd9f43500cSPL ID 65f206aa-2273-42cd-affc-abbd9f43500c
- Pharmacologic class
- Human Immunoglobulin G
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400069147602followed by a unit qualifier and the quantityPackage 00069-1476-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0069-1476
- What is NDC 0069-1476?
- 0069-1476 is the product NDC for Cutaquig (immunoglobulin g), Human immunoglobulin g 165 mg/mL solution, listed with the FDA by Pfizer Laboratories Div Pfizer Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Cutaquig (Immunoglobulin G).
- What is the active ingredient?
- Human immunoglobulin g.
- Who is the labeler?
- Pfizer Laboratories Div Pfizer Inc, NDC labeler code 0069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Cutaquig?
- 6 other product NDCs are listed under this name. See all Cutaquig NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Cutaquig products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1061 | 00069-1061-02 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1509 | 00069-1509-02 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1802 | 00069-1802-02 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1960 | 00069-1960-02 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1965 | 00069-1965-02 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Octapharma USA Inc | 68982-810 | 68982-0810-0168982-0810-0268982-0810-03+3 more |
Other NDCs under BLA 125668
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1061 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1509 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1802 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1960 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1965 |
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Octapharma USA Inc | 68982-810 |